Profil
Theo Proukou is currently the Chief HR Officer & Executive Partner at Flagship Pioneering.
Prior to this, he held various HR leadership roles at Novartis Vaccines & Diagnostics, Vertex Pharmaceuticals, TripAdvisor, and Rubius Therapeutics.
He received his undergraduate and graduate degrees from St. Bonaventure University and an MBA.
Anciens postes connus de Theo Proukou
| Sociétés | Poste | Fin |
|---|---|---|
| RUBIUS THERAPEUTICS | Human Resources Officer | 01/04/2022 |
| TRIPADVISOR, INC. | Corporate Officer/Principal | 01/02/2019 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/04/2016 |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 02/02/2014 |
Formation de Theo Proukou
| St. Bonaventure University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| TRIPADVISOR, INC. | Consumer Services |
| Entreprise privées | 2 |
|---|---|
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
